Get the Stockscreener App
1.65
1.19%
-0.03
Essa Pharma Inc stock is traded at $1.65, with a volume of 45,636.
It is down -1.19% in the last 24 hours and down -1.78% over the past month.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
See More
Previous Close:
$1.68
Open:
$1.68
24h Volume:
45,636
Relative Volume:
0.15
Market Cap:
$74.13M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
-2.5781
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
-3.49%
1M Performance:
-1.78%
6M Performance:
-72.01%
1Y Performance:
-82.47%
1-Day Range:
$1.65
$1.70
1-Week Range:
$1.65
$1.75
52-Week Range:
$1.40
$9.60
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
(778) 331-0962
Address
SUITE 720, VANCOUVER, BC
Compare EPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.65 | 74.13M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.25 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.95 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
634.75 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.67 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
112.68 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-04-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
View All
Essa Pharma Inc Stock (EPIX) Latest News
2025-03-03 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
Lost Money on ESSA Pharma Inc.(EPIX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse Publishing
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ESSA Pharma - GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel - The Bakersfield Californian
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
2025-03-02 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
UPCOMING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Stockhouse Publishing
2025-03-01 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. LawsuitEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - TradingView
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. LawsuitEPIX - Morningstar
2025-02-27 | Shareholders that lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
2025-02-27 | Investors who Lost Money on ESSA Pharma Inc. (EPIX) Should Contact Levi & Korsinsky about Pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Investors who lost money on ESSA Pharma Inc. (EPIX) should - GlobeNewswire
Investors who lost money on ESSA Pharma Inc. (EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX - TradingView
2025-02-27 | Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
The Gross Law Firm Notifies Shareholders of ESSA Pharma Inc.(EPIX) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
The Gross Law Firm Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – EPIX - GlobeNewswire
2025-02-26 | Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineEPIX - Morningstar
2025-02-24 | Shareholders that lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, IIPR, Block, and Crocs and Encourages Investors to Contact the Firm - TradingView
2025-02-24 | Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - TradingView
Class Action Filed Against ESSA Pharma Inc. (EPIX)March 25, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against ESSA Pharma Inc. (EPIX) - Stockhouse Publishing
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your RightsEPIX - PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. - GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EPIX - GlobeNewswire Inc.
2025-02-21 | Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Kilgore News Herald
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - The Malaysian Reserve
Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class ActionEPIX - The Malaysian Reserve
EPIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
2025-02-19 | Investors who Lost Money on ESSA Pharma Inc. (EPIX) Should Contact Levi & Korsinsky about Pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... - The Bakersfield Californian
Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - Stockhouse Publishing
Investors who lost money on ESSA Pharma Inc.(EPIX) should - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before ... - The Bakersfield Californian
ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
2025-02-17 | Shareholders that Lost Money on ESSA Pharma Inc. (EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:EPIX | Press Release - Stockhouse Publishing
EPIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
2025-02-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
Essa Pharma Inc Stock (EPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.23%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):